Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial(HERO -aCKD)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 429 participants.
Also called NCT07027774
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 429 participants
- Registry
-
NCT07027774
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07027774. Randomized; no masking; primary purpose treatment. Start 2025-07-10 (anticipated); primary completion 2027-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial(HERO -aCKD)
- Condition
- Chronic Kidney Disease Stage 4
- Intervention (Drug)
- Henagliflozin 5 mg Group
- Intervention (Drug)
- Henagliflozin 10 mg Group
- Intervention (Drug)
- Conventional therapy group
- Lead sponsor
- First Affiliated Hospital of Wannan Medical College
- Collaborator
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct07027774- Content hash
fc224c9472fe72d7712e49761ba2025fb492a7d2a8f914157d04642277f5c2db